“Illumina’s sequencing portfolio is the most comprehensive in the world, and the addition of the NextSeq 500 System furthers this distinction by enabling next-generation sequencing to become ...

Illumina, Inc. further demonstrated its commitment to making genomics more accessible for the potential benefit of patients today with a series of technology and partnership announcements that ...

Illumina CEO Francis deSouza on Monday unveiled two new sequencing systems designed to meet growing demand for clinical genomic data at reduced cost, as well as a collaboration with Roche focused ...

As the diagnostics industry explores innovative ways to monitor and contain bacterial infections, Illumina is joining forces with French diagnostic outfit bioMérieux to develop a next-generation ...

Illumina's genomic sequencing technology enjoys extensive citations in industry publications, and customer workflows have been developed around its systems that need to be repeated consistently.

Illumina is riding high off its HiSeq X sequencing systems, meeting increased demand with expanded facilities and ambitious plans for growth. Now, the company is rolling out a service to help labs ...

It’s been nearly 15 years since San Diego’s Illumina gained supremacy in DNA sequencing — with just a few rivals competing to deliver the equipment and chemistry to map the genome. But that ...

Illumina's genomic sequencing technology enjoys extensive citations in industry publications, and customer workflows have been developed around its systems that need to be repeated consistently.

Adaptive Biotechnologies signed a deal with Illumina, the largest genetic sequencing firm in the U.S., to produce kits that can read the human immune system to detect diseases at labs across the ...

Illumina, Inc. has announced the immediate availability of a transformative addition to its industry-leading next-generation sequencing portfolio with the launch of the NextSeq 500 System. The new ...